Table 2. Pathway of Molecular Glue Degrader Discovery and Structure-Guided Drug Design.
initial discovery | scaffold definition | optimization | validation |
---|---|---|---|
serendipitous30 | crystallography63,64 | protein–protein interaction assay of scaffold analogues68 | binding assays69 |
high-throughput screens (HTS)52,60,61 | molecular docking65,66 | E3 ligase-dependent activity assay of scaffold analogues66,67 | biochemical methods validating target degradation46,67 |
data mining62 | structure–activity relationship (SAR) studies66−68 | cell-based activity assays68 | |
molecular docking analysis67 | |||
crystallography69,70 |